diabetic retinopathy glp 1 Updated guidance from the PCDS and ABCD: Managing the national GLP-1 RA shortage Glucagon-like peptide-1 receptor agonists rescued

GLP-1 medications (semaglutide/Wegovy, tirzepatide/Zepbound) have become incredibly popular for women dealing with midlife weight gain

The same large randomized clinical trials that showed positive cardiovascular results in subjects with type 2 diabetes also reported retinopathy complications as secondary outcomes

This research provides additional evidence to suggest that discontinuing GLP-1 agonists at least 14 days before total joint replacement surgery is optimal to reduce the risk of delayed emergence from anesthesia, aspiration events, aspiration pneumonitis and conversion to intubation, said John R

The European Association for the Study of Obesity's Physical Activity Working Group reached the same conclusion independently